This Year’s Highlights
Key takeaways
Critical insights to transparency in Pharma & MD&D
Where compliance stands in the digital world
Embedding ethics and compliance into the corporate DNA
Tips and tricks for addressing compliance in high risk areas
How to integrate ABAC processes to ensure third party compliance
Progress in GDPR compliance and its re-enforcement after implementation
Compliance framework examples to interact with individual patients throughout the whole product life-cycle
Tips to compete with the new tech players entering the healthcare market
Learning from digital tech companies and their compliance strategies
Utilizing the full potential of big data analytics and automation in compliance
Future developments of three disclosure codes in the Life Sciences sector
Experience on disclosing on professional conference organizers
Best practices to identify promo vs. non-promo activity in the scientific exchange with HCPs
Understanding of the compliance landscape for RWE data and outcomes-based healthcare
Stream Focus
Pharma
Ethical interaction with patient organizations and individual patients via different channels
Value-based compliance
Automation and big data analytics in compliance
Transparency & compliance for the growing amount of RWE data in outcomes-based healthcare
Compliance landscape for AI, social media and digital health
Behind the curtains – an effective ABAC program
Compliance framework for scientific exchange with HCPs
Medical Devices & Diagnostics
How the phasing out of direct Sponsorship to HCPs has affected us
First experiences after adopting the new MedTech Europe Code of Ethical Business Practices
Insights into the transparency of educational grants
Critical considerations for compliance with EU MDR & IVDR
Prestigious speakers
- Bernhard Fischer
- Health Care Compliance Officer
- Johnson & Johnson Medical, Germany
- Mirko Lalatovic
- Head of Compliance Central and Northern Europe (CENE)
- Fresenius Medical Care, Germany
- Daniel Köhnen
- Head of Compliance – DE, AT, CH, Central
- Cardinal Health, Germany
- René Neubauer
- Director Healthcare Law
- Fresenius Medical Care, Germany
- Brett Hudson
- Head of Integrity & Compliance
- Novartis, Switzerland
- Klaus Geldsetzer
- Chief Compliance Officer
- Santen, Germany
- Karolina Czernicka-Kuhl
- Director Legal and Compliance DACH, Eastern EU & Middle East
- Vertex Pharmaceuticals, Germany
- Fausto Massimino
- Director Legal, Governance and Compliance
- Roche, Italy
REGISTRATION
Testimonials
“Very good presentations, interactive sessions, diversity of topics regarding the same subject. Excellent!”
Mihaela Scarlatescu, A&D Pharma, Romania
“Reflected on current industry issues in a pragmatic way with knowledgeable speakers.”
Savvas Palaistis, UCB, Greece
“Great networking. Very informative, with a lot of practical examples from industry and patients.”
Marina Relly, Newport Pharmaceuticals, Ireland
“I enjoyed very much the part of the congress that I attended and I believe you are totally on the right path. Fleming has a good reputation among compliance professionals, so keep it that way.”
Efi Gkika, Baxter, Switzerland
Event statistics
of attendees intend to attend again
of attendees recommend the event
of attendees appreciated the networking opportunities
Gallery
See photos from previous annual
JOIN US IN ZURICH
Zurich is the largest city in Switzerland. Many museums and art galleries can be found in the city, including the Swiss National Museum and the Kunsthaus. Zurich is a leading global city and among world's largest financial centres despite having a relatively small population.
Contact us
- Andrea Weber
- Sr. Manager for Pharma
- Phone: +421 257 272 232
- Email: event.inquiries@fleming.events
